Search results
Results from the WOW.Com Content Network
Darunavir is an Office of AIDS Research Advisory Council (DHHS) recommended treatment option for adults and adolescents, regardless of whether they have received HIV treatment in the past. [ 14 ] [ 15 ] In a study of people that had never received HIV treatment, darunavir was as effective as lopinavir / ritonavir at 96 weeks with a once-daily ...
The FDA concluded that an increase in CD4 cell counts was an indicator of how effective the drug would be against AIDS and HIV infection. Stavudine was the fourth drug to be approved for the treatment of AIDS and HIV infection by the FDA on 27 June 1994. Even after approval, studies were continued to evaluate the clinical benefit of the drug.
The use of antiretroviral therapies have decreased the risk of early mortality and improved the quality of life for people who are HIV-positive. A significant increase in the use of these medications have been seen over the years, from an estimated 7.7 million people receiving these antiretrovirals therapies in 2010, to approximately 24.5 million estimated people worldwide in 2018. [9]
Many factors may contribute to depression in adults living with HIV, such as the effects of the virus on the brain, other infections or tumours, antiretroviral drugs and other medical treatment. [74] Rates of major depression are higher in people living with HIV compared to the general population, and this may negatively influence ...
Common side effects include nausea, diarrhea, headaches, feeling tired, and cough. [1] Serious side effects include liver disease, lactic acidosis, and worsening hepatitis B among those already infected. [1] It is safe for people over three months of age and can be used during pregnancy. [1] The medication can be taken with or without food. [1]
Rilpivirine, sold under the brand names Edurant and Rekambys, is a medication, developed by Tibotec, used for the treatment of HIV/AIDS. [5] [6] It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs such as efavirenz.
Nelfinavir, sold under the brand name Viracept, is an antiretroviral medication used in the treatment of HIV/AIDS.Nelfinavir belongs to the class of drugs known as protease inhibitors (PIs) and like other PIs is almost always used in combination with other antiretroviral drugs.
It does not cure HIV/AIDS or hepatitis B. [4] [6] It is available by mouth as a tablet or powder. [4] Common side effects include nausea, rash, diarrhea, headache, pain, depression, and weakness. [4] Severe side effects include high blood lactate and an enlarged liver. [4] There are no absolute contraindications. [4]